Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024

Lynn Pulliam's Biography



Lynn Pulliam, Professor of Laboratory Medicine and Medicine, University of California San Francisco

Dr Pulliam received her BA degree from Northwestern University, her MS in Microbiology at California State University at Long Beach and her PhD in Experimental Pathology at the University of California, San Francisco (UCSF). She is a Professor of Laboratory Medicine and Medicine at UCSF and Director of Microbiology at the San Francisco VA Health Care Center. She was the Director of Research at the SF VA, the largest VA research center in the US, for 7 years. She is a founding member and past President of the International Society for Neurovirology (ISNV) as well as the Women in Neuroscience awardee and recipient of the ISNV Pioneer Award. She serves on the Board of Directors of ISNV and the Editorial Boards of several journals. She has also received awards from AmFar, the Northern California Institute for Research and Education and Drexel University Prize in Neurovirology.

Lynn Pulliam Image

Using Exosomes to Diagnose and Treat Chronic Neurodegeneration

Thursday, 26 September 2024 at 09:15

Add to Calendar ▼2024-09-26 09:15:002024-09-26 10:15:00Europe/LondonUsing Exosomes to Diagnose and Treat Chronic NeurodegenerationEmerging Technologies for Diagnostics and Liquid Biopsies - New Orleans 2024 in New OrleansNew OrleansSELECTBIOenquiries@selectbiosciences.com

Diagnosing neurocognitive disorders has been challenging and doing so without invasive and expensive procedures even more difficult. My lab has been interested in diagnosing chronic cognitive impairment in HIV infection and more recently longCOVID using neuronal-derived exosomes. The goal is to identify liquid biomarkers associated with cognitive impairment and follow these during and after treatment. In addition, studies may identify common and distinct processes in neurodegeneration that may help in drug interventions. Alternatively, exosomes can be used as therapeutic delivery vehicles. Implementing these strategies in the clinical laboratory is the goal and still a challenge.


Add to Calendar ▼2024-09-26 00:00:002024-09-27 00:00:00Europe/LondonEmerging Technologies for Diagnostics and Liquid Biopsies - New Orleans 2024Emerging Technologies for Diagnostics and Liquid Biopsies - New Orleans 2024 in New OrleansNew OrleansSELECTBIOenquiries@selectbiosciences.com